(Q38354213)

2 September 2017

Role of Val509 in time-dependent inhibition of human prostaglandin H synthase-2 cyclooxygenase activity by isoform-selective agents (English)

1 reference

2 September 2017

Guo Q

1

1 reference

2 September 2017

Wang LH

series ordinal

2

1 reference

2 September 2017

Ruan KH

series ordinal

3

1 reference

2 September 2017

Kulmacz RJ

series ordinal

4

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 August 1996

1 reference

Journal of Biological Chemistry

2 September 2017

1 reference

2 September 2017

271

1 reference

2 September 2017

19134-19139

1 reference

2 September 2017

32

1 reference

Prostaglandins and thromboxanes

2 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.32.19134

Prostaglandin synthase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.32.19134

Structural requirements for time-dependent inhibition of prostaglandin biosynthesis by anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.32.19134

Lack of covalent modification of prostaglandin synthetase (cyclo-oxygenase) by indomethacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.32.19134

Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.32.19134

Effect of inhibitor time-dependency on selectivity towards cyclooxygenase isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.32.19134

The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.32.19134

Prostaglandin H synthase-1: evaluation of C-terminus function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.32.19134

A simple method for site-directed mutagenesis using the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.32.19134

PCR amplification of up to 35-kb DNA with high fidelity and high yield from lambda bacteriophage templates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.32.19134

Human cyclooxygenase-2 cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.32.19134

Purification and characterization of prostaglandin H synthase-2 from sheep placental cotyledons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.32.19134

Comparison of recombinant cyclooxygenase-2 to native isoforms: aspirin labeling of the active site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.32.19134

Comparison of hydroperoxide initiator requirements for the cyclooxygenase activities of prostaglandin H synthase-1 and -2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.32.19134

Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.32.19134

The kinetic factors that determine the affinity and selectivity for slow binding inhibition of human prostaglandin H synthase 1 and 2 by indomethacin and flurbiprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.32.19134

Involvement of arginine 120, glutamate 524, and tyrosine 355 in the binding of arachidonate and 2-phenylpropionic acid inhibitors to the cyclooxygenase active site of ovine prostaglandin endoperoxide H synthase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.32.19134

Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.32.19134

Comparison of the construction of a 3-D model for human thromboxane synthase using P450cam and BM-3 as templates: implications for the substrate binding pocket

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.32.19134

Determination of total protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.32.19134

Purification and characterization of recombinant human cyclooxygenase-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.32.19134

Isolation and covalent structure of the aspirin-modified, active-site region of prostaglandin synthetase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.32.19134

NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.32.19134

Comparison of umbilical vein models for measurement of relative prostacyclin and thromboxane production

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.32.19134

Arginine 120 of prostaglandin G/H synthase-1 is required for the inhibition by nonsteroidal anti-inflammatory drugs containing a carboxylic acid moiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.32.19134

21 January 2018

Identifiers

DOI

10.1074/JBC.271.32.19134

1 reference

2 September 2017

1 reference